As our study is the first to validate the effect and mechanism of a Chinese medicine formula in treating NF2-associated schwannoma, further pharmacological and pharmacokinetic studies will be needed to understand the mechanisms and biological efficacy of QDSJ to optimize this therapeutic strategy. The gene discussed is NF2; the disease is schwannoma.